Selumetinib Market - Global Outlook and Forecast 2022-2028

March 2022 | 74 pages | ID: S9659EC32C41EN
Market Monitor Global

Abstracts

Koselugo (selumetinib) is inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK1/2). MEK1/2 proteins are upstream regulators of the extracellular signal-related kinase (ERK) pathway. Both MEK and ERK are critical components of the RAS-regulated RAF-MEK-ERK pathway, which is often activated in different types of cancers.

This report contains market size and forecasts of Selumetinib in global, including the following market information:

Global Selumetinib Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Selumetinib Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Selumetinib companies in 2021 (%)

The global Selumetinib market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

10 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Selumetinib include AstraZeneca and Merck etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Selumetinib manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Selumetinib Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Selumetinib Market Segment Percentages, by Type, 2021 (%)

• 10 mg
• 25 mg

Global Selumetinib Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Selumetinib Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Selumetinib Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Selumetinib Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Selumetinib revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Selumetinib revenues share in global market, 2021 (%)

Key companies Selumetinib sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Selumetinib sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Selumetinib Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Selumetinib Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SELUMETINIB OVERALL MARKET SIZE

2.1 Global Selumetinib Market Size: 2021 VS 2028
2.2 Global Selumetinib Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Selumetinib Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Selumetinib Players in Global Market
3.2 Top Global Selumetinib Companies Ranked by Revenue
3.3 Global Selumetinib Revenue by Companies
3.4 Global Selumetinib Sales by Companies
3.5 Global Selumetinib Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Selumetinib Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Selumetinib Product Type
3.8 Tier 1, Tier 2 and Tier 3 Selumetinib Players in Global Market
  3.8.1 List of Global Tier 1 Selumetinib Companies
  3.8.2 List of Global Tier 2 and Tier 3 Selumetinib Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Selumetinib Market Size Markets, 2021 & 2028
  4.1.2 10 mg
  4.1.3 25 mg
4.2 By Type - Global Selumetinib Revenue & Forecasts
  4.2.1 By Type - Global Selumetinib Revenue, 2017-2022
  4.2.2 By Type - Global Selumetinib Revenue, 2023-2028
  4.2.3 By Type - Global Selumetinib Revenue Market Share, 2017-2028
4.3 By Type - Global Selumetinib Sales & Forecasts
  4.3.1 By Type - Global Selumetinib Sales, 2017-2022
  4.3.2 By Type - Global Selumetinib Sales, 2023-2028
  4.3.3 By Type - Global Selumetinib Sales Market Share, 2017-2028
4.4 By Type - Global Selumetinib Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Selumetinib Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Selumetinib Revenue & Forecasts
  5.2.1 By Application - Global Selumetinib Revenue, 2017-2022
  5.2.2 By Application - Global Selumetinib Revenue, 2023-2028
  5.2.3 By Application - Global Selumetinib Revenue Market Share, 2017-2028
5.3 By Application - Global Selumetinib Sales & Forecasts
  5.3.1 By Application - Global Selumetinib Sales, 2017-2022
  5.3.2 By Application - Global Selumetinib Sales, 2023-2028
  5.3.3 By Application - Global Selumetinib Sales Market Share, 2017-2028
5.4 By Application - Global Selumetinib Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Selumetinib Market Size, 2021 & 2028
6.2 By Region - Global Selumetinib Revenue & Forecasts
  6.2.1 By Region - Global Selumetinib Revenue, 2017-2022
  6.2.2 By Region - Global Selumetinib Revenue, 2023-2028
  6.2.3 By Region - Global Selumetinib Revenue Market Share, 2017-2028
6.3 By Region - Global Selumetinib Sales & Forecasts
  6.3.1 By Region - Global Selumetinib Sales, 2017-2022
  6.3.2 By Region - Global Selumetinib Sales, 2023-2028
  6.3.3 By Region - Global Selumetinib Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Selumetinib Revenue, 2017-2028
  6.4.2 By Country - North America Selumetinib Sales, 2017-2028
  6.4.3 US Selumetinib Market Size, 2017-2028
  6.4.4 Canada Selumetinib Market Size, 2017-2028
  6.4.5 Mexico Selumetinib Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Selumetinib Revenue, 2017-2028
  6.5.2 By Country - Europe Selumetinib Sales, 2017-2028
  6.5.3 Germany Selumetinib Market Size, 2017-2028
  6.5.4 France Selumetinib Market Size, 2017-2028
  6.5.5 U.K. Selumetinib Market Size, 2017-2028
  6.5.6 Italy Selumetinib Market Size, 2017-2028
  6.5.7 Russia Selumetinib Market Size, 2017-2028
  6.5.8 Nordic Countries Selumetinib Market Size, 2017-2028
  6.5.9 Benelux Selumetinib Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Selumetinib Revenue, 2017-2028
  6.6.2 By Region - Asia Selumetinib Sales, 2017-2028
  6.6.3 China Selumetinib Market Size, 2017-2028
  6.6.4 Japan Selumetinib Market Size, 2017-2028
  6.6.5 South Korea Selumetinib Market Size, 2017-2028
  6.6.6 Southeast Asia Selumetinib Market Size, 2017-2028
  6.6.7 India Selumetinib Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Selumetinib Revenue, 2017-2028
  6.7.2 By Country - South America Selumetinib Sales, 2017-2028
  6.7.3 Brazil Selumetinib Market Size, 2017-2028
  6.7.4 Argentina Selumetinib Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Selumetinib Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Selumetinib Sales, 2017-2028
  6.8.3 Turkey Selumetinib Market Size, 2017-2028
  6.8.4 Israel Selumetinib Market Size, 2017-2028
  6.8.5 Saudi Arabia Selumetinib Market Size, 2017-2028
  6.8.6 UAE Selumetinib Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Selumetinib Major Product Offerings
  7.1.4 AstraZeneca Selumetinib Sales and Revenue in Global (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Selumetinib Major Product Offerings
  7.2.4 Merck Selumetinib Sales and Revenue in Global (2017-2022)
  7.2.5 Merck Key News

8 GLOBAL SELUMETINIB PRODUCTION CAPACITY, ANALYSIS

8.1 Global Selumetinib Production Capacity, 2017-2028
8.2 Selumetinib Production Capacity of Key Manufacturers in Global Market
8.3 Global Selumetinib Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 SELUMETINIB SUPPLY CHAIN ANALYSIS

10.1 Selumetinib Industry Value Chain
10.2 Selumetinib Upstream Market
10.3 Selumetinib Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Selumetinib Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Selumetinib in Global Market
Table 2. Top Selumetinib Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Selumetinib Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Selumetinib Revenue Share by Companies, 2017-2022
Table 5. Global Selumetinib Sales by Companies, (K Units), 2017-2022
Table 6. Global Selumetinib Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Selumetinib Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Selumetinib Product Type
Table 9. List of Global Tier 1 Selumetinib Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Selumetinib Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Selumetinib Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Selumetinib Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Selumetinib Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Selumetinib Sales (K Units), 2017-2022
Table 15. By Type - Global Selumetinib Sales (K Units), 2023-2028
Table 16. By Application – Global Selumetinib Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Selumetinib Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Selumetinib Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Selumetinib Sales (K Units), 2017-2022
Table 20. By Application - Global Selumetinib Sales (K Units), 2023-2028
Table 21. By Region – Global Selumetinib Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Selumetinib Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Selumetinib Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Selumetinib Sales (K Units), 2017-2022
Table 25. By Region - Global Selumetinib Sales (K Units), 2023-2028
Table 26. By Country - North America Selumetinib Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Selumetinib Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Selumetinib Sales, (K Units), 2017-2022
Table 29. By Country - North America Selumetinib Sales, (K Units), 2023-2028
Table 30. By Country - Europe Selumetinib Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Selumetinib Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Selumetinib Sales, (K Units), 2017-2022
Table 33. By Country - Europe Selumetinib Sales, (K Units), 2023-2028
Table 34. By Region - Asia Selumetinib Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Selumetinib Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Selumetinib Sales, (K Units), 2017-2022
Table 37. By Region - Asia Selumetinib Sales, (K Units), 2023-2028
Table 38. By Country - South America Selumetinib Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Selumetinib Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Selumetinib Sales, (K Units), 2017-2022
Table 41. By Country - South America Selumetinib Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Selumetinib Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Selumetinib Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Selumetinib Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Selumetinib Sales, (K Units), 2023-2028
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Selumetinib Product Offerings
Table 48. AstraZeneca Selumetinib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Selumetinib Product Offerings
Table 51. Merck Selumetinib Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Selumetinib Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 53. Global Selumetinib Capacity Market Share of Key Manufacturers, 2020-2022
Table 54. Global Selumetinib Production by Region, 2017-2022 (K Units)
Table 55. Global Selumetinib Production by Region, 2023-2028 (K Units)
Table 56. Selumetinib Market Opportunities & Trends in Global Market
Table 57. Selumetinib Market Drivers in Global Market
Table 58. Selumetinib Market Restraints in Global Market
Table 59. Selumetinib Raw Materials
Table 60. Selumetinib Raw Materials Suppliers in Global Market
Table 61. Typical Selumetinib Downstream
Table 62. Selumetinib Downstream Clients in Global Market
Table 63. Selumetinib Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Selumetinib Segment by Type
Figure 2. Selumetinib Segment by Application
Figure 3. Global Selumetinib Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Selumetinib Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Selumetinib Revenue, 2017-2028 (US$, Mn)
Figure 7. Selumetinib Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Selumetinib Revenue in 2021
Figure 9. By Type - Global Selumetinib Sales Market Share, 2017-2028
Figure 10. By Type - Global Selumetinib Revenue Market Share, 2017-2028
Figure 11. By Type - Global Selumetinib Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Selumetinib Sales Market Share, 2017-2028
Figure 13. By Application - Global Selumetinib Revenue Market Share, 2017-2028
Figure 14. By Application - Global Selumetinib Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Selumetinib Sales Market Share, 2017-2028
Figure 16. By Region - Global Selumetinib Revenue Market Share, 2017-2028
Figure 17. By Country - North America Selumetinib Revenue Market Share, 2017-2028
Figure 18. By Country - North America Selumetinib Sales Market Share, 2017-2028
Figure 19. US Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Selumetinib Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Selumetinib Sales Market Share, 2017-2028
Figure 24. Germany Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 25. France Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Selumetinib Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Selumetinib Sales Market Share, 2017-2028
Figure 33. China Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 37. India Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Selumetinib Revenue Market Share, 2017-2028
Figure 39. By Country - South America Selumetinib Sales Market Share, 2017-2028
Figure 40. Brazil Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Selumetinib Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Selumetinib Sales Market Share, 2017-2028
Figure 44. Turkey Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Selumetinib Revenue, (US$, Mn), 2017-2028
Figure 48. Global Selumetinib Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Selumetinib by Region, 2021 VS 2028
Figure 50. Selumetinib Industry Value Chain
Figure 51. Marketing Channels